Subsequent Events (Details) - USD ($) |
1 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
Nov. 13, 2020 |
Oct. 19, 2020 |
Oct. 15, 2020 |
Oct. 12, 2020 |
Jan. 24, 2020 |
Nov. 12, 2020 |
Sep. 30, 2020 |
Mar. 31, 2020 |
|
Subsequent Events (Textual) | ||||||||
Common stock, par value | $ 0.0001 | $ 0.0001 | ||||||
Issue discount | $ 501,370 | $ 405,377 | ||||||
Maturity date | Dec. 11, 2020 | |||||||
Subsequent Event [Member] | ||||||||
Subsequent Events (Textual) | ||||||||
Stock price | $ 1.19 | |||||||
Fair value options | $ 77,000 | |||||||
fully vested grant date | $ 11,000 | |||||||
Subsequent Event [Member] | Investor [Member] | ||||||||
Subsequent Events (Textual) | ||||||||
Gross proceeds | $ 750,000 | |||||||
Debt conversion, description | The Company entered into a Securities Purchase Agreement with certain institutional and accredited investors to sell to the investors senior convertible debentures, convertible into the Company’s common stock at a conversion price of $1.25 per share, subject to adjustment as set forth in the debenture. The debentures have a maturity of one year, accrue interest at the rate of 7% per year, and are subject to 12.5% original issue discount. Each investor also received a warrant to purchase a number of share of the Company’s common stock equal to 50% of the number of shares the debenture is convertible into. The warrants have a five year term, and an exercise price of $1.55 per share, subject to adjustment as set forth therein. | |||||||
Subsequent Event [Member] | Bridge Note [Member] | ||||||||
Subsequent Events (Textual) | ||||||||
Proceeds from debt | $ 250,000 | |||||||
Stock Options [Member] | Consulting Services [Member] | Subsequent Event [Member] | ||||||||
Subsequent Events (Textual) | ||||||||
Common stock, par value | $ 1.48 | |||||||
Granted shares | 25,000 | 150,000 | ||||||
Vesting period | November 12, 2020 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Vesting period. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Description of the conversion terms of a debt instrument which may include the conversion ratio (including all potential conversion ratios if contingently adjustable), type of debt or equity security into which the debt is convertible, the dollars of debt or the number of shares into which the instrument is convertible (or potentially convertible into), the conversion period, any contingencies associated with the conversion terms, and the existence and amount of a beneficial conversion feature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, after accumulated amortization, of debt discount. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|